GEP19991646B - Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions
- Google Patents
Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions
Info
Publication number
GEP19991646B
GEP19991646BGEAP1993848AGEAP1993000848AGEP19991646BGE P19991646 BGEP19991646 BGE P19991646BGE AP1993848 AGEAP1993848 AGE AP1993848AGE AP1993000848 AGEAP1993000848 AGE AP1993000848AGE P19991646 BGEP19991646 BGE P19991646B
Authority
GE
Georgia
Prior art keywords
pharmaceutical compositions
butilation
pyridil
omega
production
Prior art date
Application number
GEAP1993848A
Inventor
M Wuelfroth Petra
P Quack Guenter
Junglas Heinz
Gold Markus R
Josef Strohmeier
Peteri Dezsoe
H Leimner Juergen
Jarglis Panayiotis
Original Assignee
Mers Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mers Co Gmbh & CofiledCriticalMers Co Gmbh & Co
Priority to GEAP1993848ApriorityCriticalpatent/GEP19991646B/en
Publication of GEP19991646BpublicationCriticalpatent/GEP19991646B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
1.Technical Result Production of pharmaceutical compositions comprising butilation compounds of ether hy¬droxytoluene-omega-pyridil which have improved antilipidemic and antiatherosclerosis properties 2. Essence Butilation compound of ether hy¬droxytoluene--omega-pyridil comprises the compounds of the formula: in which m = 1, 3. When m = 1 then = 6, 9, when m = 3, then = 5, 11, where = m + n +1. Antilipidemic and antiatherosclerosis pharma¬ceu¬tical composition in the form of active ingredient comprises the mentioned compound in pharma¬ceutically effective amount and acceptable carrier. 3. Field of Application Organic chemistry, madicine. 3 ind. 7 dep. claims, 5 Tables.
GEAP1993848A1993-06-081993-06-08Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions
GEP19991646B
(en)
Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions
Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions
Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions
Tricyclic Pyrimidin Derivatives Capable of Inhibiting Tyrozine Kinases Epidermic Growth Factor Receptor, Pharmaceutical Composition Containing Them and Methods for Treatment
Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions
Benzamides as medicament for treatment of neurodegenerative state, a method for the preparation thereof (variants), pharnaceutical composition for treatment of neurodegenerative states and a method for treatment